A 6-day-old female neonate is evaluated in the neonatal intensive care unit for progressiv… — USMLE Step 2 CK

A $6$ -day-old female neonate is evaluated in the neonatal intensive care unit for progressive lethargy, vomiting, and refusal to feed over the past $24$ hours. She was born at $39$ weeks gestation via uncomplicated spontaneous vaginal delivery and was discharged home on day $2$ of life, breastfeeding exclusively. On admission, her temperature is $35.4^\circ\text{C}$ ( $95.7^\circ\text{F}$ ), heart rate is $175$ /min, respiratory rate is $65$ /min, and blood pressure is $50/30$ mmHg. Physical examination reveals a lethargic, icteric infant with profound hypotonia. There are scattered blotchy erythematous macules with tiny central pale papules on the chest and back. Hepatomegaly is palpable $4$ cm below the right costal margin.

Laboratory evaluation shows:

Test	Result
Leukocyte count	$4,200/\text{mm}^3$ ( $25\%$ bands)
Hemoglobin	$10.5\text{ g/dL}$
Platelet count	$75,000/\text{mm}^3$
Total bilirubin	$14.5\text{ mg/dL}$
Direct bilirubin	$5.2\text{ mg/dL}$
Aspartate aminotransferase (AST)	$245\text{ U/L}$
Alanine aminotransferase (ALT)	$210\text{ U/L}$
Glucose	$35\text{ mg/dL}$

Blood, urine, and cerebrospinal fluid cultures are obtained. The infant is intubated for airway protection, given normal saline boluses, and started on an intravenous infusion of $10\%$ dextrose along with empiric intravenous ampicillin and gentamicin.

Which of the following is the most appropriate additional step in the management of this patient?

A
Initiate empiric intravenous acyclovir therapy for suspected disseminated viral infection
B
Broaden antimicrobial therapy to include intravenous meropenem and vancomycin
Substitute current enteral feeds with a soy-based infant formulaAnswer
D
Perform a hepatobiliary iminodiacetic acid (HIDA) scan to evaluate for biliary atresia
E
Initiate continuous intensive phototherapy and prepare for exchange transfusion

Answer

Substitute current enteral feeds with a soy-based infant formula

This exclusively breastfed neonate presents with septic shock, profound hypoglycemia, hepatomegaly, and conjugated hyperbilirubinemia. This specific constellation of symptoms is highly characteristic of classic galactosemia (deficiency of galactose-1-phosphate uridyl transferase). Toxic accumulation of galactose-1-phosphate causes acute liver failure, renal tubular dysfunction, and cataracts. Furthermore, neonates with galactosemia have severe immune dysfunction that strongly predisposes them to Gram-negative sepsis, most notably Escherichia coli. While the sepsis is appropriately managed with the initiated ampicillin and gentamicin, resolving the underlying metabolic crisis requires immediate elimination of dietary galactose. Because breast milk and standard cow's milk formulas contain lactose (which is hydrolyzed into glucose and galactose), the correct intervention is immediately substituting enteral feeds with a galactose-free, soy-based infant formula.

Step-by-Step Solution

Analyze the clinical presentation and laboratory data to identify the primary syndrome.

The infant is in septic shock (hypothermia, tachycardia, leukopenia with a left shift, thrombocytopenia) combined with a metabolic/hepatic crisis (hypoglycemia, conjugated hyperbilirubinemia, elevated transaminases, hepatomegaly).

Recognizing the dual infectious and metabolic nature of the presentation is essential for identifying the underlying etiology.

Differentiate the cause of combined sepsis, conjugated hyperbilirubinemia, and hypoglycemia in an exclusively breastfed neonate.

This triad strongly points to classic galactosemia (galactose-1-phosphate uridyl transferase deficiency).

Galactosemia presents in the first few days of life after the initiation of milk feedings (breast milk contains lactose, which breaks down into glucose and galactose). The accumulation of galactose-1-phosphate is toxic to the liver.

Evaluate the patient's risk for specific infectious complications based on the suspected metabolic diagnosis.

Neonates with galactosemia are at a uniquely high risk for overwhelming Escherichia coli sepsis.

Elevated galactose impairs leukocyte bactericidal activity, specifically reducing neutrophil superoxide release against E. coli.

Determine the necessary management steps for the identified conditions.

The E. coli sepsis is already being treated empirically with ampicillin and gentamicin. The underlying galactose toxicity must be halted immediately.

Medical stabilization with IV fluids and antibiotics is insufficient if the patient continues to ingest the toxic substrate. Breastfeeding must be stopped immediately and replaced with a galactose-free (soy-based) formula.

Key Concept

Neonates presenting with Gram-negative sepsis, conjugated hyperbilirubinemia, hepatomegaly, and hypoglycemia after initiating milk feeds should be immediately evaluated for classic galactosemia and transitioned to a soy-based formula.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic